Clinical trials
Phase 2 Bacterial Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 3 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Furiex Pharmaceuticals, Inc | 2 |
| U.S. Army Medical Research and Development Command | 2 |
| Biomedical Advanced Research and Development Authority | 1 |
| Cardeas Pharma | 1 |
| Cellceutix Corporation | 1 |
| Debiopharm International SA | 1 |
| Forest Laboratories | 1 |
| Microbion Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bacterial Infections | 26 |
| Pneumonia | 5 |
| Infections | 4 |
| Pneumonia, Bacterial | 4 |
| Abscess | 3 |
| Cellulitis | 3 |
| Respiratory Tract Infections | 3 |
| Wound Infection | 3 |
| Gram-Negative Bacterial Infections | 2 |
| Gram-Positive Bacterial Infections | 2 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.